Status:
UNKNOWN
Fermented Millet Porridge, Gut Microbiota and Inflammation Status in Women
Lead Sponsor:
Institut de Recherche en Sciences de la Sante, Burkina Faso
Collaborating Sponsors:
University Ghent
Bill and Melinda Gates Foundation
Conditions:
Inflammation
Microbiome, Human
Eligibility:
FEMALE
18-49 years
Phase:
NA
Brief Summary
Maternal undernutrition concerns 10-19% of women of reproductive age globally, the vast majority of which live in sub Saharan Africa and south Asia. Recommendations for nutritional interventions to ta...
Eligibility Criteria
Inclusion
- Participant are
- 18 to 49 years old
- Resident in the study area and do not plan to move within 5 months following the start of the study
- Are not on antibiotic treatment on inclusion and have not been in the previous 3 weeks.
- Do not suffer from any pathology that could interfere with their diet.
- Have no known allergy to pearl millet or its derivatives
- Agree to sign a consent to participate in the study-
Exclusion
- Women under 18 or over 49
- Women not consuming pearl millet porridge due to allergy or food preference
- Women planning to move from the study area within 5 months of the start of the study
- Women with serious illnesses that may interfere with their diet
- Women on antibiotic treatment or at the time of inclusion or having been in the previous 3 weeks.
- In addition, women who will benefit from antibiotic therapy during the study will be excluded from the analysis
Key Trial Info
Start Date :
March 21 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 31 2024
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT05299970
Start Date
March 21 2022
End Date
July 31 2024
Last Update
October 23 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IRSS-DRO
Bobo-Dioulasso, Houet, Région Des hauts-Bassins, Burkina Faso, 01 BP 545